Eli Lilly and (LLY)

Akouos Securities Corporation • Akouos, Inc. • Alnara Pharmaceuticals, Inc. • Andean Technical Operations • Aparito Espanya S.L. • Aparito LLC • Aparito, Ltd. • ARMO Biosciences, Inc. • Avid Radiopharmaceuticals, Inc. • Balance Pharmacy Services, LLC ...

IRS number

350470950

LLY stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$1,048.75

Low target

$970.00

High target

$1,190.00

Latest filings (excl ownership)

View all

S-3ASR

Automatic shelf registration

Prospectus for primary offering

11 Feb 25

FWP

Free writing prospectus

10 Feb 25

424B2

Prospectus for primary offering

10 Feb 25

8-K

Lilly reports full Q4 2024 financial results and provides 2025 guidance

6 Feb 25

8-K

Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance

14 Jan 25

8-K

Lilly announces changes on board of directors

30 Oct 24

Transcripts

View all

LLY

Earnings call transcript

2024 Q4

6 Feb 25

LLY

Earnings call transcript

2024 Q3

30 Oct 24

LLY

Earnings call transcript

2024 Q2

8 Aug 24

LLY

Earnings call transcript

2024 Q1

30 Apr 24

LLY

Earnings call transcript

2023 Q4

6 Feb 24

LLY

Earnings call transcript

2023 Q3

2 Nov 23

LLY

Earnings call transcript

2023 Q2

8 Aug 23

LLY

Earnings call transcript

2023 Q2

8 Aug 23

LLY

Earnings call transcript

2023 Q1

27 Apr 23

LLY

Earnings call transcript

2022 Q4

2 Feb 23

Latest ownership filings

View all

Change in insider ownership

26 Feb 25

Change in insider ownership

25 Feb 25

144

Notice of proposed sale of securities

25 Feb 25

Change in insider ownership

24 Feb 25

Eric Dozier

21 Feb 25

Change in insider ownership

21 Feb 25

Change in insider ownership

Financial summary

Financial statements Chart LLY financial data

Quarter (USD)	Dec 24	Sep 24	Jun 24	Mar 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	3.27 bn	3.27 bn	3.27 bn	3.27 bn	3.27 bn	3.27 bn
Cash burn (monthly)	33.53 mm	(no burn)	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	69.77 mm	n/a	n/a	n/a	n/a	n/a
Cash remaining	3.20 bn	n/a	n/a	n/a	n/a	n/a
Runway (months of cash)	95.4	n/a	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q4 2024

LLY institutional ownership history Ownership history

82.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	3763	3609	+4.3%
Opened positions	445	244	+82.4%
Closed positions	291	157	+85.4%
Increased positions	1491	1536	-2.9%
Reduced positions	1434	1368	+4.8%

13F shares	Current	Prev Q	Change
Total value	496.44 tn	558.44 tn	-11.1%
Total shares	777.56 mm	681.96 mm	+14.0%
Total puts	10.98 mm	10.38 mm	+5.8%
Total calls	9.65 mm	8.12 mm	+18.8%
Total put/call ratio	1.1	1.3	-11.0%

Largest owners	Shares	Value	Change
Lilly Endowment	96.89 mm	$79.76 bn	NEW
Vanguard	74.25 mm	$57.32 tn	+0.6%
BlackRock	65.23 mm	$50.36 tn	+1.4%
PNC The PNC Financial Services Group, Inc.	51.30 mm	$39.61 tn	-0.1%
STT State Street	34.31 mm	$26.49 tn	+1.4%
FMR	30.54 mm	$23.57 tn	-7.6%
T. Rowe Price	20.86 mm	$16.11 bn	-0.3%
Capital World Investors	19.55 mm	$15.09 tn	-3.9%
Geode Capital Management	17.38 mm	$13.39 tn	+1.7%
Primecap Management	16.76 mm	$12.94 tn	-5.3%

Largest transactions	Shares	Bought/sold	Change
Lilly Endowment	96.89 mm	+96.89 mm	NEW
International Assets Investment Management	19.52 k	-12.44 mm	-99.8%
Norges Bank	10.89 mm	+10.89 mm	NEW
JPM JPMorgan Chase & Co.	14.91 mm	-3.35 mm	-18.3%
FMR	30.54 mm	-2.50 mm	-7.6%
Jennison Associates	4.80 mm	-2.15 mm	-31.0%
Wellington Management	12.63 mm	+2.01 mm	+19.0%
Capital International Investors	8.73 mm	+1.65 mm	+23.2%
Arrowstreet Capital, Limited Partnership	14.85 k	-1.61 mm	-99.1%
RJF Raymond James Financial	1.61 mm	+1.61 mm	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

LLY insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
25 Feb 25	Lilly Endowment	Common Stock	Sell	Dispose S	No	No	911.549	270	246.12 k	96,236,978
25 Feb 25	Lilly Endowment	Common Stock	Sell	Dispose S	No	No	910.533	3,606	3.28 mm	96,237,248
25 Feb 25	Lilly Endowment	Common Stock	Sell	Dispose S	No	No	909.383	3,290	2.99 mm	96,240,854
25 Feb 25	Lilly Endowment	Common Stock	Sell	Dispose S	No	No	908.292	5,191	4.71 mm	96,244,144
25 Feb 25	Lilly Endowment	Common Stock	Sell	Dispose S	No	No	907.286	4,962	4.50 mm	96,249,335
25 Feb 25	Lilly Endowment	Common Stock	Sell	Dispose S	No	No	906.46	8,559	7.76 mm	96,254,297
25 Feb 25	Lilly Endowment	Common Stock	Sell	Dispose S	No	No	905.412	11,143	10.09 mm	96,262,856
25 Feb 25	Lilly Endowment	Common Stock	Sell	Dispose S	No	No	904.54	18,159	16.43 mm	96,273,999
25 Feb 25	Lilly Endowment	Common Stock	Sell	Dispose S	No	No	903.484	36,219	32.72 mm	96,292,158
25 Feb 25	Lilly Endowment	Common Stock	Sell	Dispose S	No	No	902.486	47,905	43.23 mm	96,328,377